Virtual Event
March 8 - 12, 2021

ALL TIMES SCHEDULED ARE EASTERN STANDARD TIME (EST)


Welcome to your Pittcon 2021 Exhibitor Console!

The Exhibitor Console is your hub for all the information you need to know about exhibiting at Pittcon 2021!

Event Information Quick Links
List of Pittcon 2021 Exhibitors Exhibitor Success & ROI Center
Virtual Terms & Condition and Policies
Virtual Pittcon 2021

Methcathinone: A Study on the Impact of Stereoselectivity on Pharmacokinetics and Pharmacodynamics

  • Session Number: G06-02
Monday, March 08, 2021: 1:50 PM - 2:10 PM

Speaker(s)

Co-Author
Michelle Peace
Associate Professor
Virginia Commonwealth University
Co-Author
S. Stevens Negus
Virginia Commonwealth University
Author
Tyson Baird
Doctoral Student
Virginia Commonwealth University

Description

The United States is currently in the midst of a drug epidemic, with overdoses and drug-related deaths increasing annually. Often, the legal consequences of drug use incentivize individuals who abuse drugs to seek “legal highs” in the form of new psychoactive substances (NPS). NPS are usually closely related but poorly studied analogs of traditional drugs of abuse. Methcathinone is the beta-keto analog of the abused psychostimulant methamphetamine, and a chiral molecule that exhibits stereoselectivity. Intracranial self-stimulation (ICSS) was used to examine these stereoselective differences in rats. ICSS is an operant procedure in which subjects can respond upon a lever to receive electrical stimulation of brain reward areas, and it has been well characterized at preclinical assessment of the abuse potential of drugs. Thirteen (13) adult male Sprague-Dawley rats were anesthetized and surgically implanted with bipolar stainless-steel electrodes targeting the medial forebrain bundle. Animals were trained to respond upon a lever to receive electrical brain stimulation in one-minute frequency trials ranging from 56-158 Hz. Once stable responding was established, a range of doses of racemic methcathinone (0.10-1.0 mg/kg), R(+)-methcathinone (0.10-3.2 mg/kg), and S(-)-methcathinone (0.10-1.0 mg/kg) were administered by intraperitoneal injection, and the modulation of ICSS responding was compared. All three enantiomeric compositions of methcathinone facilitated ICSS responding in a manner consistent with other highly abused drugs. S(-)-methcathinone exhibited a 2.4-fold difference in potency to facilitate ICSS compared to R(+)-methcathinone. S(-)-methcathinone and R(+)-methcathinone had different times to peak effect. These stereoselective differences highlight the importance of bioanalytical methods that resolve individual enantiomers of chiral compounds in order to study drugs and their metabolites for forensic toxicological purposes.

Additional Info

Keywords: Please select up to 4 keywords ONLY:
Clinical/Toxicology



For Technical Support with this webpage, please contact support.